Summary
Updated Aug 30, 2026
Roger Michael Gendreau is CHIEF MEDICAL OFFICER of Dogwood Therapeutics, Inc. (DWTX). 3 SEC Form 4 filings on record going back to 2025, most recently on 6 March 2026.
Trading Pattern
InsiderAlpha's records for Roger Michael Gendreau go back to 2025: 3 primary Form 4 filings, an average of 1.5 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Sector
No other insider has filed at Roger Michael Gendreau's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Fairmount Funds Management LLC - $370.02M of COGT open-market activity in the last 12 months
- BAKER BROS. ADVISORS LP - $327.32M of CELC open-market activity in the last 12 months
- J.H. Whitney Equity Partners VII, LLC - $319.15M of AVAH open-market activity in the last 12 months
- General Atlantic (ALN HLTH), L.P. - $315.49M of ALHC open-market activity in the last 12 months
- GENERAL ATLANTIC, L.P. - $315.49M of ALHC open-market activity in the last 12 months
- August J. Troendle - $249.99M of MEDP open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Roger Michael Gendreau?
Roger Michael Gendreau is a corporate insider, tracked as CHIEF MEDICAL OFFICER of Dogwood Therapeutics, Inc. (DWTX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Roger Michael Gendreau last file a Form 4?
The most recent primary Form 4 on record is dated 6 March 2026, one of 3 filings going back to 2025.
Where can I see all of Roger Michael Gendreau's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Roger Michael Gendreau and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial